Clinical Trial Update: Efficacy And Safety Of Parecoxib IV/IM 40 Mg Vs Placebo Following Sub Muscular Breast Augmentation [Phase 4]

View source ↗

Summary

Pfizer-sponsored Phase 4 trial evaluating parecoxib for postoperative pain after submuscular breast augmentation was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Parecoxib (parecoxib)

Snippet

Sponsor: Pfizer | Conditions: Pain, Postoperative | Phase 4 | Status: WITHDRAWN